nivolumab
bms
['nivo', 'immutace', 'biomarker', 'hcc']
first data from the translational program of immutace , tace + nivo in intermediate hcc : a high pre-treatment ratio of pd1:cd8 t cells in the blood identifies responders --&gt; food for thoughts --&gt; we need biomarker in hcc.
#livercancer #hcc #immunotherapy 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine